热门资讯> 正文
Senti Biosciences GAAP EPS—0.42美元
2024-03-22 04:44
- Senti Biosciences press release (NASDAQ:SNTI): Q4 GAAP EPS of -$0.42.
- As of December 31, 2023, Senti Bio held cash, cash equivalents and short-term investments of $35.9 million
More on Senti Biosciences
- Senti Biosciences to reduce workforce by 37%
- Financial information for Senti Biosciences
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。